Podcasts

OncLive On Air^® is a podcast from OncLive^® that provides oncology professionals with the resources and information they need to provide the best patient care. Segments cover every angle of oncology practice, from new technology to treatment advances to important regulatory decisions. New episodes with exclusive interviews with leading oncology experts are released on Mondays and Thursdays.

Outlining Advances Made in Ovarian Cancer in Oklahoma City

December 25th 2019

We traveled to Oklahoma City, Oklahoma, for a State of the Science Summit™ on Ovarian Cancer, which featured insights from the Stephenson Cancer Center faculty.

Talking Tumors: Weill Cornell Medicine Experts Walk Through Challenging Breast Cancer Cases

December 18th 2019

Lisa Newman, MD, MPH, FACS, FASCO, and Alan B. Astrow, MD, discuss the need for systemic therapy in women with microinvasive triple-negative breast cancer and more intensive adjuvant therapy in women with intermediate-risk hormone receptor-positive, HER2-negative breast cancer.

Highlighting Progress Made in Hematologic Malignancies in Philly

December 11th 2019

We traveled to Philadelphia, Pennsylvania, for a State of the Science Summit™ on Hematologic Malignancies, which featured insights from the University of Pennsylvania faculty.

Checking Out Emerging Approaches in Lung Cancer Treatment in Chicago

December 4th 2019

We traveled to Chicago, Illinois, for a State of the Science Summit™ on Lung Cancer, which featured insights from the University of Chicago faculty.

Tanios Bekaii-Saab, MD: Not Just Seeing the Light, But Getting Out of the Tunnel

November 27th 2019

Dr. Tanios Bekaii-Saab spent time discussing the path to practicing in gastrointestinal malignancies, how he navigates balancing his professional and personal life, and mottos he has lived by throughout his career and while caring for his patients.

Reviewing Breakthroughs in Breast Cancer in Raleigh

November 20th 2019

We traveled to Raleigh, North Carolina, for a State of the Science Summit™ on Breast Cancer, which featured insights from the Duke Cancer Institute faculty.

Talking Tumors: Filling Data Gaps in Multiple Myeloma

November 14th 2019

We sat down with Ajai Chari, MD, and Sundar Jagannath, MD, both of Mount Sinai Hospital, to provide insight on controversial, but critical, questions regarding the merits of quadruplet versus triplet therapy in the newly diagnosed setting, the optimal maintenance approach in high-risk patients, and the data in support of and against initiating treatment in patients with smoldering multiple myeloma.

Spotlighting New Standards in Lung Cancer in Salt Lake City

November 7th 2019

We traveled to Salt Lake City, Utah, for a State of the Science Summit™ on Non–Small Cell Lung Cancer, which featured insights from the University of Utah and Intermountain Healthcare.

Howard "Skip" Burris, MD: A Passion for Befriending Patients and Always Being Kind

November 1st 2019

Howard A. Burris, MD, also known as "Skip," of Sarah Cannon Research Institute, discussed how he wound up in the oncology space, his passion for getting to know and helping his patients, and some proud moments throughout his monumental career.

Outlining Progress Made in Ovarian Cancer in Pittsburgh

October 24th 2019

We traveled to Pittsburgh, Pennsylvania, for a State of the Science Summit™ on Ovarian Cancer, which featured insights from the University of Pittsburgh Medical Center faculty.

Talking Tumors: Adaptive Approaches in Triple-Negative and HR-Positive Breast Cancers

October 16th 2019

In keeping up with the expanding breast cancer treatment armamentarium, we sat down with Jane L. Meisel, MD, and Aditya Bardia, MD, MPH, who shed light on emerging treatment strategies for patients with metastatic triple-negative breast cancer and discussed the optimal timing of genomic testing in women with progressive hormone receptor–positive disease.

Spreading Newfound Treatment Strategies in Hematologic Malignancies in Seattle

October 9th 2019

We traveled to Seattle, Washington, for a State of the Science Summit™ on Hematologic Malignancies, which featured insights from Seattle Cancer Care Alliance faculty.

Examining Major Breakthroughs Made in Breast Cancer in Milwaukee

October 2nd 2019

We traveled to Milwaukee, Wisconsin, for a State of the Science Summit™ on Breast Cancer, which featured insights from key thought leaders at Carbone Cancer Center of the University of Wisconsin.

Perusing Progress Made in Ovarian Cancer Treatment Paradigm in Pasadena

September 25th 2019

We traveled to Pasadena, California, for a State of the Science Summit™ on Ovarian Cancer, which featured insights from City of Hope faculty.

Maha Hussain, MD: Anything Is Possible With a Fire in the Belly

September 18th 2019

Maha Hussain, MD, FACP, FASCO, reflects on the path that led her into genitourinary cancers, and the challenges she has overcome in her career while offering advice to young oncologists just getting started in the field.

Gaining Ground in GI Cancers in Denver

September 11th 2019

We traveled to Denver, Colorado, for a State of the Science Summit™ on Gastrointestinal Cancers, which featured insights from University of Colorado and Rocky Mountain Cancer Centers faculty.

Mapping Multiple Myeloma Advances in NYC

September 4th 2019

We traveled to New York City, New York, for a State of the Science Summit™ on Multiple Myeloma, which featured insights from the faculty from the Mount Sinai Hospital.

Garnering Breakthroughs in GU Cancers in Boston

August 29th 2019

We traveled to Boston, Massachusetts, for a State of the Science Summit™ on Genitourinary Cancers, which featured insights from the faculty from the Dana-Farber Cancer Institute.

Mastering New Advances in Hematologic Malignancies in Milwaukee

August 21st 2019

We traveled to Milwaukee, Wisconsin, for a State of the Science Summit™ on Hematologic Malignancies, which featured insights from the faculty from the Medical College of Wisconsin.

Talking Tumors: Leveraging Immunotherapy in Nonsquamous NSCLC

August 14th 2019

Stephen V. Liu, MD, of Medstar Georgetown University Medical Center, and Konstantinos Arnaoutakis, MD, of Winthrop P. Rockefeller Cancer Institute at the University of Arkansas for Medical Sciences, discuss the results of a Twitter poll regarding the use of single-agent immunotherapy versus combination chemotherapy and immunotherapy in a patient with nonsquamous non–small cell lung cancer and to shed light on the data that support each intended treatment choice.